The browser you are using is no longer supported. Please switch to Edge or Chrome
NHS Kernow’s website closed on 30 June 2022. Visit the NHS Cornwall and Isles of Scilly Integrated Care Board website for information about our health and care services.
Publication scheme
NHS Kernow has followed guidance from the Information Commissioner and adopted the healthcare publication scheme.
The scheme helps people access information about us, the decisions we make and how we spend public money.
The pages below will provide you with information on:
- who we are and what we do
- what we spend and how we spend it
- what our priorities are
- our policies and procedures
Most of the information we produce is available on our website. However, some may be in hard copy only. You can also check if the information you are looking for is in our disclosure log. The disclosure log contains responses to all the freedom of information requests we have received in the past 2 years.
Rebate scheme
Prescribing rebate scheme
NHS Kernow has a policy to agree and consider future prescribing rebates. The arrangements for the drugs are listed below. Information correct as of 14 April 2022.
Attention deficit hyperactivity disorder: Xaggitin
Company: Ethypharm.
Product: Xaggitin.
Type: For use in the treatment of attention deficit hyperactivity disorder (ADHD).
Start date: 1 August 2017.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Product: Xaggitin.
Type: For use in the treatment of attention deficit hyperactivity disorder (ADHD).
Start date: 1 August 2017.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Anti-psychotic medicine: Zaluron XL (Quetiapine XL)
Company: Fontus Health Limited.
Product: Zaluron XL (Quetiapine XL).
Type: Anti-psychotic medicine.
Start date: 1 August 2019.
End date: 30 July 2024.
Aligned to PrescQIPP: Yes.
Product: Zaluron XL (Quetiapine XL).
Type: Anti-psychotic medicine.
Start date: 1 August 2019.
End date: 30 July 2024.
Aligned to PrescQIPP: Yes.
Atypical anti-psychotic medicine: Quetiapine Biquelle
Company: Aspire Pharma Limited.
Product: Quetiapine Biquelle.
Type: Atypical anti-psychotic medicine.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Product: Quetiapine Biquelle.
Type: Atypical anti-psychotic medicine.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Emollient for eczema: Balneum
Company: Almirall Limited.
Product: Balneum.
Type: Emollient for eczema.
Start date: 23 June 2020.
End date: 22 June 2022.
Aligned to PrescQIPP: Yes.
Product: Balneum.
Type: Emollient for eczema.
Start date: 23 June 2020.
End date: 22 June 2022.
Aligned to PrescQIPP: Yes.
Inhaler: Clenil Modulite
Company: Chiesi Limited.
Product: Clenil Modulite.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Product: Clenil Modulite.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Inhaler: Fostair NEXThaler
Company: Chiesi Limited.
Product: Fostair NEXThaler.
Type: Inhaler.
Start date: 1 May 2021.
End date: 30 April 2023.
Aligned to PrescQIPP: Yes.
Product: Fostair NEXThaler.
Type: Inhaler.
Start date: 1 May 2021.
End date: 30 April 2023.
Aligned to PrescQIPP: Yes.
Inhaler: Fostair pMDI
Company: Chiesi Limited.
Product: Fostair pMDI.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Product: Fostair pMDI.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Inhaler: Sereflo
Company: CIPLA.
Product: Sereflo.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Product: Sereflo.
Type: Inhaler.
Start date: 1 August 2021.
End date: 31 July 2023.
Aligned to PrescQIPP: Yes.
Insulin: Aprida
Company: Aventis Pharma Limited trading as Sanofi.
Product: Aprida.
Type: Insulin.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Product: Aprida.
Type: Insulin.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Insulin: Insuman
Company: Aventis Pharma Limited trading as Sanofi.
Product: Insuman.
Type: Insulin.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Product: Insuman.
Type: Insulin.
Start date: 1 April 2022.
End date: 31 March 2023.
Aligned to PrescQIPP: Yes.
Insulin: Lispro
Company: Aventis Pharma Limited trading as Sanofi.
Product: Lispro.
Type: Insulin.
Start date: 1 April 2020.
End date: 30 September 2021.
Aligned to PrescQIPP: Yes.
Product: Lispro.
Type: Insulin.
Start date: 1 April 2020.
End date: 30 September 2021.
Aligned to PrescQIPP: Yes.
Pain relief patch: Fencino
Company: DS Ashbourne Limited (Part of the Ethypharm Group).
Product: Fencino.
Type: Pain relief patch.
Start date: 1 April 2016.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Product: Fencino.
Type: Pain relief patch.
Start date: 1 April 2016.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Parkinson’s: Pipexus
Company: Ethypharm.
Product: Pipexus.
Type: For use in the treatment for Parkinson’s.
Start date: 1 July 2018.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Product: Pipexus.
Type: For use in the treatment for Parkinson’s.
Start date: 1 July 2018.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Prostate cancer: Firmagon (degarelix)
Company: Ferring Pharmaceuticals.
Product: Firmagon (degarelix).
Type: For use in the treatment for prostate cancer.
Start date: 1 September 2019.
End date: 31 December 2021.
Aligned to PrescQIPP: Yes.
Product: Firmagon (degarelix).
Type: For use in the treatment for prostate cancer.
Start date: 1 September 2019.
End date: 31 December 2021.
Aligned to PrescQIPP: Yes.
